Neosoma
About Neosoma
Neosoma is a healthcare AI company dedicated to advancing the treatment of brain cancers through an integrated portfolio of innovative, artificial intelligence-based software products combined with a Clinical Management Software Platform. The company’s core technology utilizes AI software to create a precise 3D analysis of cancerous tumors, providing physicians with critical insights into how a patient’s tumor is changing over time based on magnetic resonance imaging (MRI) sequences.
Neosoma’s comprehensive Software-as-a-Service (SaaS) solution is designed to assist neuro-oncology clinical teams in making better treatment decisions, with the ultimate goal of improving clinical outcomes, increasing clinical process efficiency, and reducing costs. Their cloud platform, Neosoma Brain Mets, and their initial software-based medical device, Neosoma HGG (High-Grade Glioma), have both received U.S. Food and Drug Administration (FDA) 510(k) clearance. Neosoma HGG, for instance, conducts detailed tumor segmentation, volumetric measurements, generates imaging for 3D geometric analysis, and longitudinally tracks patients with high-grade glioma brain tumors, offering objectivity to clinical decisions. The company is also developing a full suite of software technologies to become a leader in the neuro-oncology software field, with a pipeline that includes meningiomas, acoustic neuromas, pediatric indications, and OAR auto-segmentation.
Focus Areas
Business Intelligence
| Key Investors | Alliance of Angels, Filter Fund, TCA Venture Group, Octane (California), Hackensack Meridian Health |
| Partnerships | Nuance Precision Imaging Network (Microsoft), Calyx, Hackensack Meridian Health, University of Bern / ARTORG Center, Inselspital |
| Acquisitions | None known |
| Technology | Cloud-native, PACS-integrated, interoperable with radiation treatment and surgical planning systems, SOC2 Type II certified, HIPAA compliant, web-based, deep learning neural networks, modular platform |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Neosoma's platform offers significant advantages for neuro-oncology physicians. Leverage the AI-powered 3D volumetric analysis and longitudinal tracking for objective and precise assessment of tumor changes, which can be crucial for determining treatment response and guiding therapy adjustments. Utilize the auto-contouring feature for radiation oncology and surgical planning to save time and improve consistency. The integrated cloud platform facilitates multidisciplinary team collaboration and streamlines workflows. Remember that while the software provides highly accurate insights, it is intended to assist and not replace the clinician's final judgment or manual contouring in external systems for definitive treatment planning. The ability to track an unlimited number of brain metastases and quantify various tumor compartments (enhancing tissue, T2/FLAIR, necrosis) provides a level of detail previously challenging to obtain manually, enhancing decision-making for complex cases.
Neosoma's platform is designed for seamless integration into existing clinical environments. It is PACS-integrated, supporting automated sending of DICOM studies for analysis and offering deep linking capabilities. The technology is interoperable with various radiation treatment and surgical planning systems, including Eclipse, MIM, Gamma Plan, Stealth, and Brainlab, allowing for easy import of auto-generated GTV contours. Neosoma also partners with the Nuance Precision Imaging Network and Calyx for enhanced data sharing and clinical trial support. The cloud-based nature ensures secure, HIPAA-compliant, and SOC2 Type II certified access.
Reviews & Opinions
Videos
News, demos, and interviews about Neosoma.
Videos load interactively. If none appear, search YouTube for Neosoma →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Neosoma.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]